ChemBriefTrump Administration Advances Plan for Peptide Drugs Favored by RFK Jr.
The Trump administration is advancing a policy permitting specialty pharmacies to compound specific unregulated peptide drugs, bypassing traditional FDA vetting. This regulatory shift targets a potent
apnews · 2026-10-16 11:09